Generalized Pustular Psoriasis Clinical Trials
2 recruiting trials for Generalized Pustular Psoriasis. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Generalized Pustular Psoriasis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Across the trials that carry a phase, Phase 2 is the largest group at 50% (1 studies); the largest phase groups are Phase 2: 1, Phase 2 / Phase 3: 1.
Research is led by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1), Shanghai Huaota Biopharmaceutical Co., Ltd. (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is TQH2929 Injections (drug, 1 trial), followed by TQH2929 Placebo, HB0034.
Track Generalized Pustular Psoriasis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis
This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study, all subjects need to use TQH2929 injection/placebo. The aim was to demonstrate the...
Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis
This is a Phase IIb, long term extension study to evaluate the safety and efficacy of HB0034 in adult subjects with generalized pustular psoriasis (GPP).
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Generalized Pustular Psoriasis, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Generalized Pustular Psoriasis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Generalized Pustular Psoriasis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.